Join
Live feed
·
PRReleasevia Quantisnow
Healthwell Acquisition Corp. I logo

Starton Therapeutics Doses First Patient in Landmark STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma

ByQuantisnow·Wall Street's wire, on your screen.
HWEL· Healthwell Acquisition Corp. I
Finance

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HWEL (Healthwell Acquisition Corp. I) and more on Quantisnow.